Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -100.00% | -91.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -100.00% | -91.65% |
| Cost of Revenue | -1.13% | 2.92% | 6.87% | 18.77% | 31.48% |
| Gross Profit | 0.19% | -6.95% | -16.12% | -30.11% | -52.74% |
| SG&A Expenses | -13.01% | -39.28% | -42.85% | -42.51% | -34.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -6,350.00% | -- | -- | -- | -- |
| Total Operating Expenses | -6.62% | -17.77% | -19.00% | -14.96% | -6.86% |
| Operating Income | 6.10% | 16.14% | 15.78% | 11.49% | 1.30% |
| Income Before Tax | 25.82% | 32.91% | 36.71% | 11.09% | -36.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.82% | 32.91% | 36.71% | 11.09% | -36.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.31% | 245.63% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.40% | 14.98% | 25.71% | -0.49% | 21.19% |
| EBIT | 6.10% | 16.14% | 15.78% | 11.49% | 1.30% |
| EBITDA | 5.55% | 16.74% | 17.16% | 13.49% | 5.02% |
| EPS Basic | 23.90% | 20.18% | 20.40% | 2.40% | 23.16% |
| Normalized Basic EPS | 60.61% | 47.77% | 40.27% | 5.87% | 10.50% |
| EPS Diluted | 23.90% | 20.18% | 20.40% | 2.40% | 23.16% |
| Normalized Diluted EPS | 60.61% | 47.77% | 40.27% | 5.87% | 10.50% |
| Average Basic Shares Outstanding | 151.07% | 33.00% | 3.57% | 2.95% | 2.83% |
| Average Diluted Shares Outstanding | 151.07% | 33.00% | 3.57% | 2.95% | 2.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |